Ovarian cancer: New drug may prevent recurrence
New research in mice identifies a compound that prevents ovarian cancer recurrence by eradicating the cancer stem-like cells that conventional chemotherapy leaves behind. New findings could change the face of ovarian cancer treatment. According to the National Cancer Institute, there were over 22,000 new cases of ovarian cancer in the United States in 2018. More…